T Sakane|H Nagafuchi - JoVE Visualize

Showing results (91-100 of 172) with videos related to

Pageof 18

Sort By:

Journal of Clinical & Laboratory Immunology|May 1, 1985

Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandinY Niwa, T Sakane, Y Fukuda, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 1988

Methyltransferase and phospholipase A2 activity in the cell membrane of neutrophils and lymphocytes from patients with Behçet's disease, systemic lupus erythematosus, and rheumatoid arthritisY Niwa, Y Miyachi, T Sakane, et al.

Arthritis and Rheumatism|March 20, 1998

Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitroS Wakisaka, N Suzuki, N Saito, et al.

Revista Paulista De Medicina|May 1, 1990

[Common bile duct syndrome in children]U Tannuri, P T Sakane, H H Marques, et al.

Molecular Immunology|August 1, 1985

Reverse relationship between lysosomal-enzyme release and active-oxygen generation in stimulated human neutrophilsY Niwa, T Sakane, M Yokoyama, et al.

Jornal De Pediatria|March 1, 1996

[Congenital Malaria. Case reports and a brief review of literature]H H Marques, M G Vallada, P T Sakane, et al.

Clinical and Experimental Immunology|February 1, 1995

Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)T Suzuki, N Suzuki, E G Engleman, et al.

Archives of Dermatology|January 1, 1985

Neutrophil-generated active oxygens in linear IgA bullous dermatosisY Niwa, T Sakane, M Shingu, et al.

Chemical & Pharmaceutical Bulletin|September 1, 1991

The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drugT Sakane, M Akizuki, S Yamashita, et al.

Arthritis and Rheumatism|June 1, 1997

In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's diseaseN Suzuki, S Kaneko, M Ichino, et al.

Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:

Pageof 18

Journal of Clinical & Laboratory Immunology|May 1, 1985

Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandinY Niwa, T Sakane, Y Fukuda, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 1988

Methyltransferase and phospholipase A2 activity in the cell membrane of neutrophils and lymphocytes from patients with Behçet's disease, systemic lupus erythematosus, and rheumatoid arthritisY Niwa, Y Miyachi, T Sakane, et al.

Arthritis and Rheumatism|March 20, 1998

Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitroS Wakisaka, N Suzuki, N Saito, et al.

Revista Paulista De Medicina|May 1, 1990

[Common bile duct syndrome in children]U Tannuri, P T Sakane, H H Marques, et al.

Molecular Immunology|August 1, 1985

Reverse relationship between lysosomal-enzyme release and active-oxygen generation in stimulated human neutrophilsY Niwa, T Sakane, M Yokoyama, et al.

Jornal De Pediatria|March 1, 1996

[Congenital Malaria. Case reports and a brief review of literature]H H Marques, M G Vallada, P T Sakane, et al.

Clinical and Experimental Immunology|February 1, 1995

Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)T Suzuki, N Suzuki, E G Engleman, et al.

Archives of Dermatology|January 1, 1985

Neutrophil-generated active oxygens in linear IgA bullous dermatosisY Niwa, T Sakane, M Shingu, et al.

Chemical & Pharmaceutical Bulletin|September 1, 1991

The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drugT Sakane, M Akizuki, S Yamashita, et al.

Arthritis and Rheumatism|June 1, 1997

In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's diseaseN Suzuki, S Kaneko, M Ichino, et al.

Pageof 18